Top

Published in:

08-08-2023 | Heart Failure

Electronic Health Record Embedded Strategies for Improving Care of Patients With Heart Failure

Authors: Michael A. Fuery, Bashar Kadhim, Marc D. Samsky, James V. Freeman, Katherine Clark, Nihar R. Desai, Francis P. Wilson, Treeny Ahmed, Tariq Ahmad

Published in: Current Heart Failure Reports | Issue 4/2023

Abstract

Purpose

A majority of clinical decisions use the electronic health record (EHR) and there is an unmet need to use its capability to help providers to make evidence-based decisions that improve care for heart failure patients. These electronic nudges are rooted in the human psychology of decision-making and often target specific cognitive biases. This review outlines the development of novel EHR nudges and specific lessons learned from each experience to inform the development of future interventions.

Recent Findings

There have been several randomized clinical trials examining the impact of EHR alerts on quality of care for heart failure patients. These interventions have targeted both clinicians and patients. There are features of each trial that inform best practices and future directions for EHR nudges.

Summary

Recent clinical trials have demonstrated that some EHR alerts can improve care for heart failure patients. These trials utilized default options, involved clinicians in the alert design process, provided actionable recommendations, and aimed to minimize disruptions to typical workflow. Alerts aimed at improving care should be examined in a randomized fashion in order to evaluate their impact on clinician satisfaction and patient care.

Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;6(3):17. https://doi.org/10.1038/s41746-020-0221-y.CrossRef

Clinical decision support. HealthIT.gov. https://www.healthit.gov/topic/safety/clinical-decision-support. Published April 10, 2018. Accessed February 28, 2023.

Blumenthal D, Tavenner M. The, “meaningful use” regulation for electronic health records. N Engl J Med. 2010;363(6):501–4. https://doi.org/10.1056/NEJMp1006114.CrossRefPubMed

Last BS, Buttenheim AM, Timon CE, Mitra N, Beidas RS. Systematic review of clinician-directed nudges in healthcare contexts. BMJ Open. 2021;11(7):e048801. https://doi.org/10.1136/bmjopen-2021-048801.CrossRefPubMedPubMedCentral

• Chen Y, Harris S, Rogers Y, Ahmad T, Asselbergs FW. Nudging within learning health systems: next generation decision support to improve cardiovascular care. Eur Heart J. 2022;43(13):1296–306. https://doi.org/10.1093/eurheartj/ehac030. This paper reviews recent EHR alerts in cardiovascular medicine and outlines the key infrastructure to promote evidence generation using nudges within a learning health system.CrossRefPubMedPubMedCentral

Ahmad T, Desai NR. Quadruple therapy is the new standard of care for HFrEF. JACC Heart Fail. 2020;8(10):819–21. https://doi.org/10.1016/j.jchf.2020.06.004.CrossRefPubMed

Greene SJ, Butler J, Albert NM, DeVore AD, Sharma PP, Duffy CI, Hill CL, McCague K, Mi X, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Fonarow GC. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72(4):351–66. https://doi.org/10.1016/j.jacc.2018.04.070.CrossRefPubMed

Greene SJ, Fonarow GC, DeVore AD, Sharma PP, Vaduganathan M, Albert NM, Duffy CI, Hill CL, McCague K, Patterson JH, Spertus JA, Thomas L, Williams FB, Hernandez AF, Butler J. Titration of medical therapy for heart failure with reduced ejection fraction. J Am Coll Cardiol. 2019;73(19):2365–83. https://doi.org/10.1016/j.jacc.2019.02.015.CrossRefPubMedPubMedCentral

Van Spall HGC, Fonarow GC, Mamas MA. Underutilization of guideline-directed medical therapy in heart failure: can digital health technologies PROMPT change? J Am Coll Cardiol. 2022;79(22):2214–8. https://doi.org/10.1016/j.jacc.2022.03.351.CrossRefPubMed

10.

Fiuzat M, Ezekowitz J, Alemayehu W, Westerhout CM, Sbolli M, Cani D, Whellan DJ, Ahmad T, Adams K, Piña IL, Patel CB, Anstrom KJ, Cooper LS, Mark D, Leifer ES, Felker GM, Januzzi JL, O’Connor CM. Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT trial: a secondary analysis of a randomized clinical trial. JAMA Cardiol. 2020;5(7):757–64. https://doi.org/10.1001/jamacardio.2020.0640.CrossRefPubMed

11.

Selvaraj S, Fonarow GC, Sheng S, Matsouaka RA, DeVore AD, Heidenreich PA, Hernandez AF, Yancy CW, Bhatt DL. Association of electronic health record use with quality of care and outcomes in heart failure: an analysis of get with the guidelines-heart failure. J Am Heart Assoc. 2018;7(7):e008158. https://doi.org/10.1161/JAHA.117.008158.CrossRefPubMedPubMedCentral

12.

Waddell KJ, Shah PD, Adusumalli S, Patel MS. Using behavioral economics and technology to improve outcomes in cardio-oncology. JACC CardioOncol. 2020;2(1):84–96. https://doi.org/10.1016/j.jaccao.2020.02.006.CrossRefPubMedPubMedCentral

13.

Dean M, Kıbrıs Ö, Masatlioglu Y. Limited attention and status quo bias. J Econ Theory. 2017;169:93–127.CrossRef

14.

Chang LL, DeVore AD, Granger BB, Eapen ZJ, Ariely D, Hernandez AF. Leveraging behavioral economics to improve heart failure care and outcomes. Circulation. 2017;136(8):765–72. https://doi.org/10.1161/CIRCULATIONAHA.117.028380.CrossRefPubMed

15.

Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, Woodward M, Patel A, McMurray J, MacMahon S. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail. 2014;2(5):440–6. https://doi.org/10.1016/j.jchf.2014.04.008.CrossRefPubMed

16.

Ouwerkerk W, Voors AA, Zwinderman AH. Factors influencing the predictive power of models for predicting mortality and/or heart failure hospitalization in patients with heart failure. JACC Heart Fail. 2014;2(5):429–36. https://doi.org/10.1016/j.jchf.2014.04.006.CrossRefPubMed

17.

Lee DS, Lee JS, Schull MJ, Borgundvaag B, Edmonds ML, Ivankovic M, McLeod SL, Dreyer JF, Sabbah S, Levy PD, O’Neill T, Chong A, Stukel TA, Austin PC, Tu JV. Prospective validation of the emergency heart failure mortality risk grade for acute heart failure. Circulation. 2019;139(9):1146–56. https://doi.org/10.1161/CIRCULATIONAHA.118.035509.CrossRefPubMed

18.

Ahmad T, Yamamoto Y, Biswas A, Ghazi L, Martin M, Simonov M, Hsiao A, Kashyap N, Velazquez EJ, Desai NR, Wilson FP. REVeAL-HF: design and rationale of a pragmatic randomized controlled trial embedded within routine clinical practice. JACC Heart Fail. 2021;9(6):409–19. https://doi.org/10.1016/j.jchf.2021.03.006.CrossRefPubMed

19.

Ahmad T, Desai NR, Yamamoto Y, Biswas A, Ghazi L, Martin M, Simonov M, Dhar R, Hsiao A, Kashyap N, Allen L, Velazquez EJ, Wilson FP. Alerting clinicians to 1-year mortality risk in patients hospitalized with heart failure: the REVEAL-HF randomized clinical trial. JAMA Cardiol. 2022;7(9):905–12. https://doi.org/10.1001/jamacardio.2022.2496.CrossRefPubMedPubMedCentral

20.

Ghazi L, Desai NR, Simonov M, Yamamoto Y, O’Connor KD, Riello RJ, Huang J, Olufade T, McDermott J, Inzucchi SE, Velazquez EJ, Wilson FP, Ahmad T. Rationale and design of a cluster-randomized pragmatic trial aimed at improving use of guideline directed medical therapy in outpatients with heart failure: PRagmatic trial of messaging to providers about treatment of heart failure (PROMPT-HF). Am Heart J. 2022;244:107–15. https://doi.org/10.1016/j.ahj.2021.11.010.CrossRefPubMed

21.

• Ghazi L, Yamamoto Y, Riello RJ, Coronel-Moreno C, Martin M, O’Connor KD, Simonov M, Huang J, Olufade T, McDermott J, Dhar R, Inzucchi SE, Velazquez EJ, Wilson FP, Desai NR, Ahmad T. Electronic alerts to improve heart failure therapy in outpatient practice: a cluster randomized trial. J Am Coll Cardiol. 2022;79(22):2203–13. https://doi.org/10.1016/j.jacc.2022.03.338. This work highlights several of the central features that enable successful EHR nudges in heart failure: specific actionable information, comparison with a guideline, clinician designed, and triggered at efficient point in workflow.CrossRefPubMed

22.

Gravelin LM, Yuhas J, Remetz M, Radford M, Foley J, Lampert R. Use of a screening tool improves appropriate referral to an electrophysiologist for implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. Circ Cardiovasc Qual Outcomes. 2011;4(2):152–6. https://doi.org/10.1161/CIRCOUTCOMES.110.956987.CrossRefPubMed

23.

Chokshi M, McNamara RL, Rajeswaran Y, Lampert R. Effect of a reminder statement on echocardiography reports on referrals for implantable cardioverter-defibrillators for primary prevention. Am J Cardiol. 2017;119(3):478–82. https://doi.org/10.1016/j.amjcard.2016.10.018.CrossRefPubMed

24.

Venechuk GE, Khazanie P, Page RL 2nd, Knoepke CE, Helmkamp LJ, Peterson PN, Pierce K, Thompson JS, Huang J, Strader JR, Dow TJ, Richards L, Trinkley KE, Kao DP, McIlvennan CK, Magid DJ, Buttrick PM, Matlock DD, Allen LA. An electronically delivered, patient-activation tool for Intensification of medications for chronic heart failure with reduced ejection fraction: rationale and design of the EPIC-HF trial. Am Heart J. 2020;229:144–55. https://doi.org/10.1016/j.ahj.2020.08.013.CrossRefPubMed

25.

Allen LA, Venechuk G, McIlvennan CK, Page RL 2nd, Knoepke CE, Helmkamp LJ, Khazanie P, Peterson PN, Pierce K, Harger G, Thompson JS, Dow TJ, Richards L, Huang J, Strader JR, Trinkley KE, Kao DP, Magid DJ, Buttrick PM, Matlock DD. An electronically delivered patient-activation tool for intensification of medications for chronic heart failure with reduced ejection fraction: the EPIC-HF trial. Circulation. 2021;143(5):427–37. https://doi.org/10.1161/CIRCULATIONAHA.120.051863.CrossRefPubMed

26.

McGreevey JD 3rd, Mallozzi CP, Perkins RM, Shelov E, Schreiber R. Reducing alert burden in electronic health records: state of the art recommendations from four health systems. Appl Clin Inform. 2020;11(1):1–12. https://doi.org/10.1055/s-0039-3402715.CrossRefPubMedPubMedCentral

27.

Shanafelt TD, Dyrbye LN, West CP. Addressing physician burnout: the way forward. JAMA. 2017;317(9):901–2. https://doi.org/10.1001/jama.2017.0076.CrossRefPubMed

28.

Wilson FP, Shashaty M, Testani J, Aqeel I, Borovskiy Y, Ellenberg SS, Feldman HI, Fernandez H, Gitelman Y, Lin J, Negoianu D, Parikh CR, Reese PP, Urbani R, Fuchs B. Automated, electronic alerts for acute kidney injury: a single-blind, parallel-group, randomised controlled trial. Lancet. 2015;385(9981):1966–74. https://doi.org/10.1016/S0140-6736(15)60266-5.CrossRefPubMedPubMedCentral

29.

Blecker S, Austrian JS, Horwitz LI, Kuperman G, Shelley D, Ferrauiola M, Katz SD. Interrupting providers with clinical decision support to improve care for heart failure. Int J Med Inform. 2019;131:103956. https://doi.org/10.1016/j.ijmedinf.2019.103956.CrossRefPubMedPubMedCentral

30.

Osheroff JA, Teich J, Levick D, Saldana L, Velasco F, Sittig D, Rogers K, & Jenders R (2012) Improving outcomes with clinical decision support: an implementer’s guide, Second Edition (2nd ed.). HIMSS Publishing. https://doi.org/10.4324/9780367806125.

Title: Electronic Health Record Embedded Strategies for Improving Care of Patients With Heart Failure
Authors: Michael A. Fuery
Bashar Kadhim
Marc D. Samsky
James V. Freeman
Katherine Clark
Nihar R. Desai
Francis P. Wilson
Treeny Ahmed
Tariq Ahmad
Publication date: 08-08-2023
Publisher: Springer US
Keywords: Heart Failure
Care
Published in: Current Heart Failure Reports / Issue 4/2023
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI: https://doi.org/10.1007/s11897-023-00614-0

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

2024 ASCO Annual Meeting

Springer Medicine

Abstract

Purpose

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2023

Medical Management of Right Ventricular Dysfunction in Pulmonary Arterial Hypertension

Pathophysiology and Treatment Opportunities of Iron Deficiency in Heart Failure: Is There a Need for Further Trials?

Growth Differentiation Factor 15 (GDF-15), a New Biomarker in Heart Failure Management

Non-Alcoholic Fatty Liver Disease as an Emerging Risk Factor for Heart Failure

Management of Ventricular Arrhythmias in Heart Failure

Sex-related differences in heart failure diagnosis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials